Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2916) 2916
Magazine Article (20) 20
Book / eBook (4) 4
Book Chapter (1) 1
Newsletter (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2313) 2313
science & technology (2126) 2126
life sciences & biomedicine (2101) 2101
anti-allergic agents - therapeutic use (1501) 1501
male (1487) 1487
female (1334) 1334
anti-allergic agents - administration & dosage (1262) 1262
adult (993) 993
biological and medical sciences (852) 852
animals (851) 851
medical sciences (826) 826
allergy (809) 809
immunology (706) 706
middle aged (684) 684
treatment outcome (653) 653
pharmacology & pharmacy (605) 605
anti-allergic agents - pharmacology (588) 588
adolescent (549) 549
pharmacology. drug treatments (504) 504
child (478) 478
anti-allergic agents - adverse effects (472) 472
double-blind method (436) 436
rhinitis, allergic, seasonal - drug therapy (414) 414
mice (375) 375
aged (355) 355
administration, intranasal (348) 348
asthma - drug therapy (321) 321
asthma (315) 315
rhinitis, allergic, perennial - drug therapy (307) 307
allergies (281) 281
abridged index medicus (274) 274
rats (272) 272
administration, oral (267) 267
omalizumab (249) 249
allergic rhinitis (244) 244
young adult (226) 226
dose-response relationship, drug (214) 214
immunoglobulin e (212) 212
conjunctivitis, allergic - drug therapy (210) 210
dermatology (206) 206
time factors (202) 202
fluticasone (200) 200
histamine h1 antagonists - therapeutic use (195) 195
hypersensitivity - drug therapy (194) 194
histamine and antagonists. allergy (193) 193
anti-allergic agents - pharmacokinetics (191) 191
allergy and immunology (190) 190
histamine (187) 187
fundamental and applied biological sciences. psychology (186) 186
drug therapy (185) 185
child, preschool (184) 184
androstadienes - administration & dosage (180) 180
immunoglobulin e - immunology (176) 176
immunopathology (176) 176
disease models, animal (175) 175
immunoglobulin e - blood (175) 175
mice, inbred balb c (175) 175
anti-allergic agents (173) 173
analysis (170) 170
mast cells - drug effects (168) 168
quality of life (168) 168
drug therapy, combination (165) 165
urticaria - drug therapy (164) 164
anti-inflammatory agents - therapeutic use (156) 156
administration, topical (150) 150
care and treatment (150) 150
fundamental immunology (148) 148
rhinitis (148) 148
administration, inhalation (144) 144
drug administration schedule (142) 142
mometasone furoate (142) 142
chronic disease (141) 141
anti-allergic agents - chemistry (140) 140
allergens - immunology (139) 139
allergens (137) 137
antihistamines (135) 135
histamine h1 antagonists - administration & dosage (135) 135
chemistry, medicinal (131) 131
physical sciences (130) 130
respiratory system (130) 130
chemistry (129) 129
general & internal medicine (128) 128
allergic diseases (127) 127
severity of illness index (127) 127
inflammation (126) 126
anti-inflammatory agents - administration & dosage (125) 125
immunotherapy (123) 123
cross-over studies (115) 115
ophthalmic solutions (115) 115
plant extracts - pharmacology (113) 113
allergic reaction (112) 112
androstadienes - therapeutic use (112) 112
asthma - immunology (112) 112
pediatrics (112) 112
sarcoidosis. granulomatous diseases of unproved etiology. connective tissue diseases. elastic tissue diseases. vasculitis (112) 112
medicine, general & internal (111) 111
internal medicine (110) 110
terfenadine - analogs & derivatives (109) 109
urticaria (109) 109
otorhinolaryngology (106) 106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2750) 2750
Japanese (141) 141
German (55) 55
French (29) 29
Chinese (22) 22
Spanish (20) 20
Russian (19) 19
Italian (13) 13
Polish (8) 8
Swedish (7) 7
Czech (6) 6
Hungarian (6) 6
Danish (5) 5
Portuguese (3) 3
Romanian (3) 3
Bulgarian (2) 2
Croatian (1) 1
Dutch (1) 1
Icelandic (1) 1
Korean (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ameliorative effects of Artemisia pallens in a murine model of ovalbumin-induced allergic asthma via modulation of biochemical perturbations
by Mukherjee, Anwesha A and Kandhare, Amit D and Rojatkar, Supada R and Bodhankar, Subhash L
Biomedicine & pharmacotherapy, ISSN 0753-3322, 10/2017, Volume 94, pp. 880 - 889
Ovalbumin | TNF-α | IgE | Nrf-2 | TGF-β | Artemisia pallens | IL’s | Airway hyperresponsiveness | Asthma | IL's | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Bronchoalveolar Lavage Fluid | Ovalbumin - immunology | Plant Extracts - pharmacology | Male | Anti-Allergic Agents - pharmacology | Dose-Response Relationship, Drug | Plant Extracts - administration & dosage | Anti-Asthmatic Agents - isolation & purification | Respiratory Hypersensitivity - drug therapy | Anti-Allergic Agents - isolation & purification | Asthma - immunology | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - isolation & purification | Disease Models, Animal | Anti-Asthmatic Agents - pharmacology | Artemisia - chemistry | Anti-Inflammatory Agents - pharmacology | Down-Regulation | Rats | Respiratory Hypersensitivity - immunology | Asthma - drug therapy | Rats, Sprague-Dawley | Animals | Anti-Asthmatic Agents - administration & dosage | Respiratory Function Tests | Anti-Allergic Agents - administration & dosage | Albumin | Transforming growth factors | Analysis | Antioxidants | Immunoglobulin E | Bone morphogenetic proteins | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema
by Wu, S-H and Chen, X-Q and Liu, B and Wu, H-J and Dong, L
British journal of dermatology (1951), ISSN 0007-0963, 01/2013, Volume 168, Issue 1, pp. 172 - 178
Life Sciences & Biomedicine | Dermatology | Science & Technology | Severity of Illness Index | Double-Blind Method | Humans | Infant | Male | Treatment Outcome | Administration, Cutaneous | Pregnadienediols - administration & dosage | Anti-Inflammatory Agents - adverse effects | Dermatitis, Atopic - drug therapy | Lipoxins - administration & dosage | Anti-Allergic Agents - adverse effects | Lipoxins - adverse effects | Quality of Life | Anti-Inflammatory Agents - administration & dosage | Female | Mometasone Furoate | Ointments - administration & dosage | Anti-Allergic Agents - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma
by Smit, Marieke and Zuidhof, Annet B and Bos, Sophie I. T and Maarsingh, Harm and Gosens, Reinoud and Zaagsma, Johan and Meurs, Herman
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 02/2014, Volume 348, Issue 2, pp. 303 - 310
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Bronchodilator Agents - therapeutic use | Respiratory Mucosa - drug effects | Bronchodilator Agents - administration & dosage | Male | Protective Agents - therapeutic use | Bronchi - immunology | Respiratory Hypersensitivity - pathology | Bronchi - drug effects | Dose-Response Relationship, Drug | Respiratory Mucosa - pathology | Histamine - metabolism | Respiratory Hypersensitivity - drug therapy | Bronchoconstriction - drug effects | Respiratory Mucosa - immunology | Scopolamine Derivatives - administration & dosage | Adrenergic beta-2 Receptor Agonists - therapeutic use | Bronchi - metabolism | Animals, Outbred Strains | Drug Therapy, Combination | Bronchi - pathology | Histamine - administration & dosage | Scopolamine Derivatives - therapeutic use | Cholinergic Antagonists - therapeutic use | Disease Models, Animal | Tiotropium Bromide | Guinea Pigs | Benzoxazines - administration & dosage | Drug Administration Schedule | Respiratory Hypersensitivity - metabolism | Administration, Inhalation | Respiratory Hypersensitivity - immunology | Benzoxazines - therapeutic use | Cholinergic Antagonists - administration & dosage | Anti-Allergic Agents - therapeutic use | Drug Synergism | Animals | Adrenergic beta-2 Receptor Agonists - administration & dosage | Protective Agents - administration & dosage | Respiratory Mucosa - metabolism | Anti-Allergic Agents - administration & dosage
Journal Article
Details down arrow
4. Full Text Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
by Broesby‐Olsen, S and Vestergaard, H and Mortz, C. G and Jensen, B and Havelund, T and Hermann, A. P and Siebenhaar, F and Møller, M. B and Kristensen, T. K and Bindslev‐Jensen, C and Mastocytosis Ctr Odense Univ Hosp and Mastocytosis Centre Odense University Hospital (MastOUH)
Allergy (Copenhagen), ISSN 0105-4538, 01/2018, Volume 73, Issue 1, pp. 230 - 238
KIT D816V | mastocytosis | anaphylaxis | omalizumab | mast cell disorders | systemic mastocytosis | tryptase | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Anaphylaxis - etiology | Omalizumab - adverse effects | Mastocytosis, Systemic - drug therapy | Anaphylaxis - prevention & control | Humans | Middle Aged | Symptom Assessment | Male | Treatment Outcome | Mastocytosis, Systemic - diagnosis | Omalizumab - administration & dosage | Anti-Allergic Agents - therapeutic use | Young Adult | Anti-Allergic Agents - adverse effects | Biomarkers | Quality of Life | Adult | Female | Omalizumab - therapeutic use | Anti-Allergic Agents - administration & dosage | Skin - pathology | Prevention | Mast cell disease | Anaphylaxis | Mastocytosis | Therapy | Medical treatment | Immunoglobulin E | Patients | Quality of life | Alleles | Tryptase | Monoclonal antibodies | Skin | Quality assessment | Safety | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control study
by Lieberman, Phillip L., MD and Umetsu, Dale T., MD, PhD and Carrigan, Gillis J., PhD, MSc and Rahmaoui, Abdelkader, MD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 138, Issue 3, pp. 913 - 915.e2
Allergy and Immunology | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Omalizumab - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Male | Asthma - drug therapy | Case-Control Studies | Anti-Allergic Agents - therapeutic use | Anaphylaxis - chemically induced | Anti-Allergic Agents - adverse effects | Adult | Female | Omalizumab - therapeutic use | Analysis | Product development | Food allergies | Population | Drug dosages | Risk factors | Asthma | Food | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Topical treatments for blepharokeratoconjunctivitis in children
by O'Gallagher, Michael and Bunce, Catey and Hingorani, Melanie and Larkin, Frank and Tuft, Stephen and Dahlmann‐Noor, Annegret and Dahlmann‐Noor, Annegret
Cochrane library, ISSN 1465-1858, 02/2017, Volume 2017, Issue 2, pp. CD011965 - CD011965
Blepharitis | Keratitis | Anti‐Allergic Agents | Outer eye | Conjunctiva | Randomized Controlled Trials as Topic | Conjunctival disease | Keratoconjunctivitis | Corneal disease | Eyelid disease | Loteprednol Etabonate | Anti‐Bacterial Agents | Eyelids | Tobramycin | Eyes & vision | Medicine General & Introductory Medical Sciences | Administration, Topical | Conjunctiva - microbiology | Humans | Loteprednol Etabonate - administration & dosage | Child, Preschool | Tobramycin - administration & dosage | Infant | Eyelids - microbiology | Keratoconjunctivitis - drug therapy | Blepharitis - drug therapy | Anti-Allergic Agents - adverse effects | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Child | Anti-Allergic Agents - administration & dosage | Infant, Newborn | Tobramycin - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs
by McGinnity, Dermot F and Collington, J and Austin, R.P and Riley, R.J
Current drug metabolism, ISSN 1389-2002, 06/2007, Volume 8, Issue 5, pp. 463 - 479
Clinical dose | Absorption | Hepatocytes | Drug metabolism | Bioavailability | Clearance | Pharmacokinetics | Volume of distribution at steady state | In vitro-in vivo extrapolation | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cardiovascular Agents - administration & dosage | Administration, Oral | Humans | Dose-Response Relationship, Drug | Tissue Distribution | Anti-Allergic Agents - pharmacokinetics | Central Nervous System Agents - pharmacokinetics | Anti-Infective Agents - administration & dosage | Models, Biological | Anti-Infective Agents - pharmacokinetics | Central Nervous System Agents - administration & dosage | Cardiovascular Agents - pharmacokinetics | Anti-Allergic Agents - administration & dosage
Journal Article
Details down arrow
8. Full Text Anti-inflammatory thioredoxin family proteins for medicare, healthcare and aging care
by Yodoi, Junji and Matsuo, Yoshiyuki and Tian, Hai and Masutani, Hiroshi and Inamoto, Takashi
Nutrients, ISSN 2072-6643, 10/2017, Volume 9, Issue 10, p. 1081
Redox | Oxidative stress | Inflammation | Thioredoxin-interacting protein | Thioredoxin | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Recombinant Proteins - therapeutic use | Dermatitis - immunology | Humans | Pneumonia, Viral - drug therapy | Aging - drug effects | Drugs, Investigational - therapeutic use | Drugs, Investigational - metabolism | Drugs, Investigational - chemistry | Food Hypersensitivity - immunology | Thioredoxins - genetics | Anti-Allergic Agents - chemistry | Acute Lung Injury - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Thioredoxins - chemistry | Peptide Fragments - genetics | Thioredoxins - therapeutic use | Recombinant Proteins - metabolism | Gastritis - drug therapy | Thioredoxins - administration & dosage | Peptide Fragments - administration & dosage | Recombinant Proteins - chemistry | Pneumonia, Viral - immunology | Recombinant Proteins - administration & dosage | Anti-Allergic Agents - therapeutic use | Gene Expression Regulation - drug effects | Peptide Fragments - chemistry | Animals | Anti-Allergic Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Food Hypersensitivity - prevention & control | Gastritis - immunology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Drugs, Investigational - administration & dosage | Acute Lung Injury - immunology | Peptide Fragments - therapeutic use | Food Hypersensitivity - drug therapy | Oxidative Stress - drug effects | Anti-Allergic Agents - administration & dosage | Dermatitis - drug therapy | Stress (physiology) | Health care | Vegetables | Grain | Radiation | Biological stress | Dermatitis | Inflammatory diseases | Proteins | Reperfusion | Ischemia | Aging | Food hypersensitivity | Plants (botany) | Medicare | Allergies | Chemical damage | Injury prevention | Lungs | Government programs | Irradiation | Hypoxia | Skin | Radiation damage | Index Medicus | thioredoxin-interacting protein | inflammation | thioredoxin | oxidative stress | redox
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Aggression behaviour induced by oral administration of the Janus-kinase inhibitor tofacitinib, but not oclacitinib, under stressful conditions
by Fukuyama, Tomoki and Tschernig, Thomas and Qi, Yulin and Volmer, Dietrich A and Bäumer, Wolfgang
European journal of pharmacology, ISSN 0014-2999, 10/2015, Volume 764, pp. 278 - 282
Mice | Tofacitinib | Aggression | Janus-Kinase inhibitor | Oclacitinib | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pyrroles - pharmacokinetics | Male | Janus Kinases - metabolism | Protein Kinase Inhibitors - adverse effects | Brain - metabolism | Dermatitis, Atopic - chemically induced | Anti-Inflammatory Agents - adverse effects | Pruritus - drug therapy | Anti-Inflammatory Agents - therapeutic use | Pyrroles - adverse effects | Anti-Inflammatory Agents - pharmacokinetics | Behavior, Animal - drug effects | Female | Piperidines - pharmacokinetics | Pyrroles - therapeutic use | Pruritus - chemically induced | Disease Models, Animal | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Sulfonamides - pharmacokinetics | Toluene 2,4-Diisocyanate | Anti-Allergic Agents - therapeutic use | Janus Kinases - antagonists & inhibitors | Anti-Allergic Agents - pharmacokinetics | Pruritus - metabolism | Animals | Dermatitis, Atopic - drug therapy | Sulfonamides - therapeutic use | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Anti-Allergic Agents - adverse effects | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Stress, Psychological | Mice, Inbred BALB C | Aggression - drug effects | Dermatitis, Atopic - metabolism | Isocyanates | Mutual fund industry | Pruritus | Analysis | Cells | Allergy | Allergic reaction | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Use of Prescription Drugs in Athletes
by Alaranta, Antti and Alaranta, Hannu and Helenius, Ilkka
Sports medicine (Auckland), ISSN 0112-1642, 2008, Volume 38, Issue 6, pp. 449 - 463
Drug monitoring | Drug utilisation | Sports | Medicine & Public Health | Sports Medicine | Life Sciences & Biomedicine | Sport Sciences | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Medical sciences | Vertebrates: body movement. Posture. Locomotion. Flight. Swimming. Physical exercise. Rest. Sports | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Humans | Anti-Allergic Agents - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Anti-Bacterial Agents - adverse effects | Anti-Asthmatic Agents - administration & dosage | Anti-Bacterial Agents - administration & dosage | Drug Prescriptions | Anti-Allergic Agents - administration & dosage | Doping in Sports | Drugs and athletes | Complications and side effects | Antiasthmatic agents | Dosage and administration | Research | Athletes | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights